Novogene Co (688315.SS) Stock Price

Novogene Co Price

SSE·CLOSED
18.93
​
Market closed

Over the last 10 years Novogene Co grew revenue by 21.7% annually, reaching 2.21 B CNY. Earnings per share have grown at 21.0% per year over the last 10 years. For Novogene Co, the net margin of 7.5% is down versus 12.1% a few years ago. At today's price the dividend yield works out to roughly 0.26%. The payout ratio is around 12% of earnings. The consensus 12-month price target for Novogene Co is 15.79 CNY, about 16.6% below where the stock trades today. Of 6 analysts, 4 rate the stock a buy — an overall Buy consensus.

Novogene Co stock price

Access this data via the Eulerpool API

Novogene Co business model & stock analysis

Novogene Co., Ltd. engages in the provision of genomic services and solutions. The company is headquartered in Beijing, Beijing and currently employs 2,284 full-time employees. The company went IPO on 2021-04-13. The firm mainly relies on high-throughput sequencing technology and bioinformatics analysis technology to establish gene sequencing platforms. Combined with multi-omics research technology, the Company provides multi-level scientific and research technical services and solutions for life science basic research, medical and clinical application research. Based on the technology accumulation in gene sequencing and its application fields, the Company independently develops genetic testing medical equipment. The firm's services mainly include life science basic scientific research services, medical research and technical services, and database-building sequencing platform services. Its other services and products include gene mutation detection kits, coronavirus disease nucleic acid test service and DA8600 sequencers. The firm conducts its businesses in domestic and overseas markets.

Frequently asked questions about Novogene Co

Analysts currently set an average price target of 16.10 CNY for the Novogene Co stock (median: 15.79 CNY), implying -25.9 % versus the latest price. The consensus is based on 6 analyst ratings.

6 analysts currently rate the Novogene Co stock: 4 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Novogene Co to generate revenue of 2.44 B CNY and earnings per share of 0.55 CNY.

Converted at the current exchange rate, the Novogene Co share trades at 2.52 EUR (18.93 CNY).

The Novogene Co share (688315.SS) is listed on 1 stock exchanges, including: Shanghai (688315.SS).

The expected revenue of Novogene Co is 2.44 B CNY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Novogene Co is 213.19 M CNY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Novogene Co is currently 34.18. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Novogene Co stock.

The price-to-sales ratio (P/S) of Novogene Co is currently 2.98. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Novogene Co stock.

The Eulerpool Quality Score for Novogene Co is 5/10.

The ISIN of Novogene Co is CNE1000052X3. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Novogene Co is 688315.SS. The ticker symbol is used to trade Novogene Co shares on the stock exchange.

Fair ValueTerminal
19.31 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue per Employee
967,442.21 CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
CNY
Initial public offering
Apr 13, 2021
ISIN
CNE1000052X3
Cusip
Y641E2104
Market capitalization
7.76 B CNYMid Cap
52-Week Range
PEG
4.98
P/E ratio
P/Ee 2026
36.40
P/Ee 2027
32.08
P/Ee 2028
28.25
P/S
P/Se
2.98
EV/EBIT
40.10
P/B Ratio
2.93
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
6.26 %
Dividend
Dividend yield
0.26 %
Est. Dividend Yield
0.24 %
Payout Ratio
11.59 %
Dividend growth Ø5Y
-5.59 %
Dividend payments per year
1
Dividend paid since
4 years
Dividend not reduced since
2 years
Dividend increased since
2 years
Dividend withholding tax
10.00 %
Last updated Oct 9, 2026, 8:52 PM

Novogene Co Peer Group

Novogene Co Ticker

SHH · 688315.SS

Novogene Co FIGI

688315:CH · BBG00FGBH9Z8688315:CG · BBG00MXGT1V1688315:C1 · BBG01FRB0YC3

All fundamentals and in-depth analysis of Novogene Co

Our stock analysis for Novogene Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Novogene Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.